Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Keflex and plaquenil Side effects of hydroxychloroquin Hydroxychloroquine is still a safe and beneficial drug for use in rheumatic diseases. Retinal toxicity is unpredictable and can occur even at relatively low doses of hydroxychloroquine. There are new screening modalities for early detection of asymptomatic hydroxychloroquine ocular toxicity. Although hydroxychloroquine is widely used in Spain, mainly in application to rheumatological disorders, very few cases of intoxication caused by this drug have been reported to date. The present clinical case describes the basic characteristics of hydroxychloroquine intoxication, and provides a review of the guidelines for using the drug. Hydroxychloroquine HCQ; Plaquenil is used increasingly in the management of a variety of autoimmune disorders, with well established roles in dermatology and rheumatology and emerging roles in. Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. This medicine is not effective against all strains of malaria. El hydroxychloroquine often used in combination Hydroxychloroquine Side Effects, Dosage, Uses, and More, Hydroxychloroquine, a potentially lethal drug Medicina. Plaquenil for raynaud's syndromeHow does plaquenil treat sjogren& 39Plaquenil and sun sensitivity Antimalarial therapy with chloroquine or hydroxychloroquine often shows marked improvement and complete resolution of the disease with a dose of 200-400 mg/day for 2 weeks and can be considered a first-line agent alone or in combination with a synthetic corticosteroid. Eosinophilic Annular Erythema - Dermatology Advisor. Hydroxychloroquine retinopathy Eye. . Uses Hydroxychloroquine is used to prevent or treat malaria infections caused by mosquito bites. It does not work against certain types of malaria chloroquine-resistant. That has been used as a single agent or in combination with methotrexate for the treatment of rheumatoid arthritis. Indeed, current clinical trials are trying to use chloroquine or hydroxychloroquine, alone or in combination with other drugs to inhibit autophagy during breast cancer therapy since chemotherapy and radiation, regimens that are used to treat breast cancer, are known to induce autophagy in cancer cells.